Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Biomarkers & Precision Medicine | Whitepapers & Reports

Immune Cell-mediated Killing of A549 Cancer Target Cells in Real-time

01 November 2023
Nanion Technologies GmbH, Munich. TUM, Munich
Open document in a new tab

Related Resources

New Research into Newborn Gut Microbiome Identifies Three “Pioneer Bacteria” for Babies’ Microbiota Development

The researchers analysed high-resolution genomic information from over 1,200 babies and identified three pioneer bacteria that drive the development of the gut microbiota.
Read More

AI-Enabled Predictive Biomarker for Patient Response to Immunotherapy Using Easy-to-Measure Features

The predictive biomarker does not require multi-omic or screening data, but rather routine clinical features.
Read More